Call Now: +1 858 800 3101 Email: info@innopep.com
Shopping Cart
0 Item(s) - $0.00
Your shopping cart is empty!
SL9, HIV - 1 p17 (77 - 85)
| Overview | |
|---|---|
| Description | This is a HLA-A2 restricted, optimal CTL epitope. SL9 is the actual epitope processed and presented in HIV-1-infected cell lines. SL9 is located in a variable region of HIV-1 Gag and many isolates show variations in this sequence. It is also known as HIV-1 LAI (77-85) |
| Sequence | SLYNTVATL |
| Sequence (3 Letter) | H-Ser-Leu-Tyr-Asn-Thr-Val-Ala-Thr-Leu-OH |
| Molecular Weight | 981.1 |
| Properties | |
| Purity | > 95% By HPLC |
| Storage | Store at -20 °C, cap vial tightly at all times. |
Ref: Brander, C. et al. J. Clin. Invest 101, 2559 (1998); Goulder,P. et al. J. Exp. Med 185, 1423 (1997)
About InnoPep
InnoPep Inc. is a company started by a couple of researchers with decades of expertise in peptide synthesis and conjugation aimed at enabling.